Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Prestige Biopharma Limited
Prestige Biopharma Receives FDA Fast Track Designation for PBP1510 in the Treatment of Pancreatic Cancer
March 21, 2023
From
Prestige Biopharma Limited
Via
Business Wire
Prestige Biopharma Develops First-in-Class PAUF-detecting Diagnostic Kit, a Powerful Tool for Early Detection of Pancreatic Cancer
March 09, 2023
From
Prestige Biopharma Limited
Via
Business Wire
Prestige Biopharma Submitted Pre-BLA Type 4 Meeting Request to FDA for Herceptin Biosimilar
October 13, 2022
From
Prestige Biopharma Limited
Via
Business Wire
Prestige Biopharma and Intas Pharmaceuticals Announce Partnership to Commercialize Bevacizumab Biosimilar in the US, Europe, Canada, MENA, Brazil, Mexico, South Africa, CIS and the SEA countries
July 26, 2022
From
Prestige Biopharma Limited
Via
Business Wire
US FDA Approves Prestige Biopharma’s IND for Phase 1/2a Trial of First-in-Class Pancreatic Cancer Treatment, PBP1510
June 27, 2022
From
Prestige Biopharma Limited
Via
Business Wire
Prestige Biopharma Receives 2022 Asia-Pacific Bioprocessing Excellence Awards
March 31, 2022
From
Prestige Biopharma Limited
Via
Business Wire
Prestige Biopharma Enters MOU with Vaxine for Supply of COVID-19 Vaccine and Co-development of COVID-19/Influenza Combo Vaccine
March 29, 2022
From
Prestige Biopharma Limited
Via
Business Wire
Prestige BioPharma’s Herceptin Biosimilar, Tuznue®, Receives EU-GMP Certification
February 21, 2022
From
Prestige BioPharma Limited
Via
Business Wire
Prestige BioPharma Commences Construction of Innovative Discovery Center (IDC) in Busan, Korea
December 19, 2021
From
Prestige BioPharma Limited
Via
Business Wire
Prestige BioPharma Announces Grand Opening of Global-Scale Vaccine Center in South Korea
November 30, 2021
From
Prestige BioPharma Limited
Via
Business Wire
Prestige Biopharma’s First-in-Class Pancreatic Cancer Treatment, PBP1510, Receives Approval for Clinical Trial in France
June 20, 2021
From
Prestige BioPharma Limited
Via
Business Wire
Prestige BioPharma Enters MOU with Busan City for Establishment of its R&D Centre in Busan, South Korea
May 18, 2021
From
Prestige BioPharma Limited
Via
Business Wire
Prestige Biopharma’s New Vaccine Production Centre for Infectious Diseases Including COVID-19
April 20, 2021
From
Prestige Biopharma Limited
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.